A detailed history of Halter Ferguson Financial Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Halter Ferguson Financial Inc. holds 5,833 shares of LLY stock, worth $4.57 Million. This represents 2.75% of its overall portfolio holdings.

Number of Shares
5,833
Previous 5,693 2.46%
Holding current value
$4.57 Million
Previous $5.15 Billion 0.26%
% of portfolio
2.75%
Previous 3.66%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $108,099 - $134,402
140 Added 2.46%
5,833 $5.17 Billion
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $4.33 Million - $5.43 Million
-5,974 Reduced 51.2%
5,693 $5.15 Billion
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $230,958 - $308,989
-390 Reduced 3.23%
11,667 $9.08 Billion
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $6.33 Million - $7.46 Million
12,057 New
12,057 $7.03 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Halter Ferguson Financial Inc. Portfolio

Follow Halter Ferguson Financial Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Halter Ferguson Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Halter Ferguson Financial Inc. with notifications on news.